Search results for: Value-Based Pricing
Filter search results
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…It found that people believe treatments should be prioritised based on the severity of a health condition and place greater value on treatments for severe conditions than is currently reflected…
Meng Li
20 August 2025
Meng Li is an Assistant Professor at the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center and a nonresident fellow at the Leonard D….
Lavni Varyani
19 September 2025
…Group (now IQVIA), specializing in market access, pricing pathways, tendering and procurement processes, and commercial effectiveness. Her expertise includes the Saudi HTA system and spans diagnostics and high-value innovations across…
Neil Grubert
12 January 2026
…of Global Market Access Insights. Since 2014, he has been working as an independent global market access consultant, trainer, and writer. He is a leading voice on pharmaceutical pricing and…
Salah Ghabri
12 March 2026
…at the University of Rennes. His interests revolve around economic evaluation of health interventions, economic modelling, uncertainty and sharing risk/pricing analysis, and HTA methods. He is member of different ISPOR…
Lunchtime Seminar: Willingness-to-Pay
9 June 2010
…in Germany to elicit the WTP for modern insulin therapy using a long-acting insulin analogue rather than conventional insulin. WTP values were found to exceed the extra treatment cost, justifying…
Reminder: Willingness-to-Pay Seminar
5 July 2010
Willingness-to-Pay for a New Pharmaceutical: Is it Worth the Money? Whose Money? During this OHE Lunchtime Seminar, Prof Peter Zweifel, University of Zurich, will discuss the findings from a discrete-choice experiment conducted…
The UK’s Publicly Funded Vaccines Market
23 November 2010
…whom are medical/scientific experts. (Plans are to increase membership soon, adding more lay members and a health economist.) Decisions are based on both science and economics, with the JCVI applying NICE’s…
The Market for Biosimilars
25 January 2011
This publication expands on the series of posts published earlier on this blog. It reports on a seminar intended to encourage further thought about the distinguishing characteristics of the market…